Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage. (2018)

First Author: Li J
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2017-09-806356

PubMed Identifier: 29282219

Publication URI: http://europepmc.org/abstract/MED/29282219

Type: Journal Article/Review

Volume: 131

Parent Publication: Blood

Issue: 6

ISSN: 0006-4971